{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:57:21Z","timestamp":1774007841707,"version":"3.50.1"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.bone.2020.115538","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T13:51:03Z","timestamp":1595857863000},"page":"115538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Suppressors of cytokine signaling (SOCS) proteins in inflammatory bone disorders"],"prefix":"10.1016","volume":"140","author":[{"given":"Mariana Rates Gonzaga","family":"Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celso M.","family":"Queiroz-Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mila Fernandes Moreira","family":"Madeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana Sim\u00e3o","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2020.115538_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2015.09.037","article-title":"SOCS3 and its role in associated diseases","author":"Yin","year":"2015","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.bone.2020.115538_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2005.04.042","article-title":"Controlling cytokine signaling by constitutive inhibitors","author":"Rakesh","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bone.2020.115538_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/nri1226","article-title":"Regulation of JAK-STAT signalling in the immune system","author":"Shuai","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bone.2020.115538_bb0020","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.174.5.3024","article-title":"Suppressors of cytokine signaling-1 and -3 regulate osteoclastogenesis in the presence of inflammatory cytokines","author":"Ohishi","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2020.115538_bb0025","doi-asserted-by":"crossref","DOI":"10.1177\/0022034516645332","article-title":"SOCS-3 regulates alveolar bone loss in experimental periodontitis","author":"Papathanasiou","year":"2016","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2020.115538_bb0030","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.028456","article-title":"Suppressor of cytokine signaling 2 (Socs2) deletion protects bone health of mice with DSS-induced inflammatory bowel disease","author":"Dobie","year":"2018","journal-title":"DMM Dis. Model. Mech."},{"key":"10.1016\/j.bone.2020.115538_bb0035","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M204819200","article-title":"1\u03b1,25-dihydroxyvitamin D 3 inhibits GH-induced expression of SOCS-3 and CIS and prolongs growth hormone signaling via the Janus kinase (JAK2)\/signal transducers and activators of transcription (STAT5) system in osteoblast-like cells","author":"Morales","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115538_bb0040","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.170.7.3679","article-title":"The possible role of TGF-\u03b2-induced suppressors of cytokine signaling expression in osteoclast\/macrophage lineage commitment in vitro","author":"Fox","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2020.115538_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2008.10.006","article-title":"Fibroblast growth factor inhibits interferon \u03b3-STAT1 and interleukin 6-STAT3 signaling in chondrocytes","author":"Krejci","year":"2009","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bone.2020.115538_bb0050","doi-asserted-by":"crossref","DOI":"10.4248\/BR201301003","article-title":"Osteoclasts: new insights","author":"Xu","year":"2013","journal-title":"Bone Res."},{"key":"10.1016\/j.bone.2020.115538_bb0055","article-title":"\u201cOsteoimmunology\u201d offers new perspectives for the treatment of pathological bone loss","author":"Liu","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.bone.2020.115538_bb0060","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4049\/jimmunol.138.3.775","article-title":"Tumor necrosis factors \u03b1 and \u03b2 induce osteoblastic cells to stimulate osteoclastic bone resorption","volume":"138","author":"Thomson","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2020.115538_bb0065","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M705578200","article-title":"Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal","author":"Javed","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115538_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-\u03b2 family signalling","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bone.2020.115538_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.20579","article-title":"SOCS-2 interferes with myotube formation and potentiates osteoblast differentiation through upregulation of JunB in C2C12 cells","author":"Ouyang","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bone.2020.115538_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2014.05.015","article-title":"Regulation of cortical and trabecular bone mass by communication between osteoblasts, osteocytes and osteoclasts","author":"Sims","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bone.2020.115538_bb0085","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-physiol-021119-034425","article-title":"Osteoclasts provide coupling signals to osteoblast lineage cells through multiple mechanisms","author":"Sims","year":"2020","journal-title":"Annu. Rev. Physiol."},{"issue":"12","key":"10.1016\/j.bone.2020.115538_bb0090","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1073\/pnas.87.12.4828","article-title":"Total absence of colony-stimulating factor 1 in the macrophage- deficient osteopetrotic (op\/op) mouse [published erratum appears in Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5937]","volume":"87","author":"Wiktor-Jedrzejczak","year":"1990","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.bone.2020.115538_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bone.2020.115538_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/181849","article-title":"Immunological reaction in TNF-\u03b1-mediated osteoclast formation and bone resorption in vitro and in vivo","author":"Kitaura","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.bone.2020.115538_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: A novel secreted protein involved in the regulation of bone density","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bone.2020.115538_bb0110","doi-asserted-by":"crossref","DOI":"10.1172\/JCI40568","article-title":"Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice mice","author":"Walker","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2020.115538_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01664","article-title":"Osteoimmunology of oral and maxillofacial diseases: Translational applications based on biological mechanisms","author":"Alvarez","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bone.2020.115538_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.2592","article-title":"NF-\u03baB has a direct role in inhibiting Bmp- and Wnt-induced matrix protein expression","author":"Tarapore","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115538_bb0125","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA119.008074","article-title":"IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis","author":"McGregor","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115538_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/art.33504","article-title":"Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway","author":"Matzelle","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2020.115538_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/S8756-3282(02)00915-8","article-title":"Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism","author":"Kudo","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115538_bb0140","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M203836200","article-title":"Regulation of receptor activator of NF-\u03baB ligand-induced osteoclastogenesis by endogenous interferon-\u03b2 (INF-\u03b2) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs in IFN-\u03b2-inhibited osteoclast formation","author":"Hayashi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115538_bb0145","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M610701200","article-title":"NF-\u03baB p50 and p52 regulate receptor activator of NF-\u03baB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1","author":"Yamashita","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115538_bb0150","first-page":"1","article-title":"A controversial role for IL-12 in immune response and bone resorption at apical periodontal sites","volume":"2010","author":"Queiroz-Junior","year":"2010","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.bone.2020.115538_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/imr.12302","article-title":"Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system","author":"Walsh","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bone.2020.115538_bb0160","doi-asserted-by":"crossref","DOI":"10.1101\/gad.13.8.1015","article-title":"TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling","author":"Lomaga","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.bone.2020.115538_bb0165","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA118.002649","article-title":"Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity","author":"Brenke","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115538_bb0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.canlet.2020.05.021","article-title":"Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis","volume":"488","author":"Bishop","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bone.2020.115538_bb0175","article-title":"Ischemic preconditioning-induced SOCS-1 protects rat intestinal ischemia reperfusion injury via degradation of TRAF6","author":"Liu","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bone.2020.115538_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038384","article-title":"SOCS2-induced proteasome-dependent TRAF6 degradation: a common anti-inflammatory pathway for control of innate immune responses","author":"McBerry","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.bone.2020.115538_bb0185","doi-asserted-by":"crossref","DOI":"10.1210\/me.2005-0301","article-title":"Suppressor of cytokine signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6\/TAK1 complex","author":"Frob\u00f8se","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bone.2020.115538_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.342","article-title":"Socs1 and Socs3 degrades Traf6 via polyubiquitination in LPS-induced acute necrotizing pancreatitis","author":"Zhou","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bone.2020.115538_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2019.03.001","article-title":"Targeting SOCS proteins to control JAK-STAT signalling in disease","author":"Durham","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bone.2020.115538_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00500","article-title":"The JAK\/STAT pathway in skeletal muscle pathophysiology","author":"Moresi","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bone.2020.115538_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.molimm.2006.11.025","article-title":"Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease","author":"O\u2019Sullivan","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bone.2020.115538_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","author":"Yoshimura","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bone.2020.115538_bb0215","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M300489200","article-title":"Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells","author":"Yu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115538_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00357","article-title":"SOCS proteins in macrophage polarization and function","author":"Wilson","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bone.2020.115538_bb0225","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M010074200","article-title":"The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2","author":"Kamizono","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115538_bb0230","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-18-1503","article-title":"Phosphorylation of SOCS1 inhibits the SOCS1-p53 tumor suppressor axis","author":"Saint-Germain","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2020.115538_bb0235","article-title":"The molecular basis of JAK\/STAT inhibition by SOCS1","author":"Liau","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bone.2020.115538_bb0240","series-title":"Curr. Top. Microbiol. Immunol","doi-asserted-by":"crossref","DOI":"10.1007\/82_2017_63","article-title":"SOCS1: Regulator of T cells in autoimmunity and cancer","author":"Ilangumaran","year":"2017"},{"key":"10.1016\/j.bone.2020.115538_bb0245","doi-asserted-by":"crossref","DOI":"10.1007\/s00774-006-0685-0","article-title":"Osteoblast differentiation is impaired in SOCS-1-deficient mice","author":"Abe","year":"2006","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2020.115538_bb0250","article-title":"SOCS2: Physiological and pathological functions","author":"Letellier","year":"2016","journal-title":"Front. Biosci. - Elit."},{"key":"10.1016\/j.bone.2020.115538_bb0255","doi-asserted-by":"crossref","DOI":"10.1203\/01.PDR.0000148735.21084.D3","article-title":"Reduced bone mineral density in SOCS-2-deficient mice","author":"Lorentzon","year":"2005","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bone.2020.115538_bb0260","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M110.132084","article-title":"Suppressor of cytokine signaling 3 inhibits LPS-induced IL-6 expression in osteoblasts by suppressing CCAAT\/enhancer-binding protein","author":"Yan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115538_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00920-x","article-title":"Bone corticalization requires local SOCS3 activity and is promoted by androgen action via interleukin-6","author":"Cho","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bone.2020.115538_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.joca.2019.05.018","article-title":"Deleting suppressor of cytokine signaling-3 in chondrocytes reduces bone growth by disrupting mitogen-activated protein kinase signaling","author":"Liu","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bone.2020.115538_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.56666","article-title":"Cortical bone maturation in mice requires SOCS3 suppression of gp130\/STAT3 signalling in osteocytes","volume":"9","author":"Walker","year":"2020","journal-title":"Elife."},{"key":"10.1016\/j.bone.2020.115538_bb0280","article-title":"Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells","author":"Lin","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bone.2020.115538_bb0285","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2017.6941","article-title":"Protective effects of SOCS3 overexpression in high glucose-induced lung epithelial cell injury through the JAK2\/STAT3 pathway","author":"Duan","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bone.2020.115538_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/nm1269","article-title":"Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis","author":"Jo","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2020.115538_bb0295","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.31594","article-title":"Mimetics of suppressor of cytokine signaling 3: novel potential therapeutics in triple breast cancer","author":"La Manna","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bone.2020.115538_bb0300","doi-asserted-by":"crossref","DOI":"10.1021\/acsmedchemlett.9b00664","article-title":"Chimeric peptidomimetics of SOCS 3 able to interact with JAK2 as anti-inflammatory compounds","author":"La Manna","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bone.2020.115538_bb0305","article-title":"Structure-activity studies of peptidomimetics based on kinase-inhibitory region of suppressors of cytokine signaling 1","author":"La Manna","year":"2017","journal-title":"Biopolymers."},{"key":"10.1016\/j.bone.2020.115538_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2018.07.020","article-title":"A cell penetrating peptide from SOCS-1 prevents ocular damage in experimental autoimmune uveitis","author":"Ahmed","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bone.2020.115538_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00183","article-title":"SOCS1 mimetics and antagonists: A complementary approach to positive and negative regulation of immune function","author":"Ahmed","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bone.2020.115538_bb0320","article-title":"Expression of STAT3-regulated genes in circulating CD4+ T cells discriminates rheumatoid arthritis independently of clinical parameters in early arthritis","author":"Anderson","year":"2019","journal-title":"Rheumatol. (United Kingdom)"},{"key":"10.1016\/j.bone.2020.115538_bb0325","series-title":"Rheumatoid Arthritis, Lancet","author":"Smolen","year":"2016"},{"key":"10.1016\/j.bone.2020.115538_bb0330","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-016-1116-9","article-title":"Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis","author":"Bugatti","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2020.115538_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00679","article-title":"Osteoimmunology of bone loss in inflammatory rheumatic diseases","author":"Coury","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bone.2020.115538_bb0340","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-214827","article-title":"Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase","author":"Takeuchi","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2020.115538_bb0345","doi-asserted-by":"crossref","DOI":"10.1186\/ar4162","article-title":"Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6\/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes","author":"Choe","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2020.115538_bb0350","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kem198","article-title":"The expression of SOCS is altered in rheumatoid arthritis","author":"Isom\u00e4ki","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.bone.2020.115538_bb0355","doi-asserted-by":"crossref","DOI":"10.1186\/ar1445","article-title":"Resistance to IL-10 inhibition of interferon gamma production and expression of suppressor of cytokine signaling 1 in CD4+ T cells from patients with rheumatoid arthritis","author":"Yamana","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2020.115538_bb0360","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-008-0006-0","article-title":"The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients","author":"Tsao","year":"2008","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.bone.2020.115538_bb0365","doi-asserted-by":"crossref","DOI":"10.1002\/art.22915","article-title":"BAFF synthesis by rheumatoid synoviocytes is positively controlled by \u03b15\u03b21 integrin stimulation and is negatively regulated by tumor necrosis factor \u03b1 and toll-like receptor ligands","author":"Alsaleh","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2020.115538_bb0370","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20021820","article-title":"Inhibition of interleukin 10 signaling after fc receptor ligation and during rheumatoid arthritis","author":"Ji","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bone.2020.115538_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/art.38701","article-title":"Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritis","author":"Liu","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bone.2020.115538_bb0380","doi-asserted-by":"crossref","DOI":"10.1172\/JCI25660","article-title":"SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis","author":"Wong","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2020.115538_bb0385","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2007-03-079178","article-title":"The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo","author":"Boyle","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.bone.2020.115538_bb0390","doi-asserted-by":"crossref","DOI":"10.1172\/JCI13568","article-title":"Induction of the cytokine signal regulator SOCS3\/CIS3 as a therapeutic strategy for treating inflammatory arthritis","author":"Shouda","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2020.115538_bb0395","doi-asserted-by":"crossref","DOI":"10.1002\/art.24072","article-title":"Splenic suppressor of cytokine signaling 3 transgene expression affects T cell responses and prevents development of collagen-induced arthritis","author":"Veenbergen","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2020.115538_bb0400","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2011.154815","article-title":"A pivotal role for antigen-presenting cells overexpressing SOCS3 in controlling invariant NKT cell responses during collagen-induced arthritis","author":"Veenbergen","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2020.115538_bb0405","doi-asserted-by":"crossref","DOI":"10.1172\/JCI16156","article-title":"Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and t cell activation","author":"Egan","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2020.115538_bb0410","doi-asserted-by":"crossref","DOI":"10.1002\/art.20302","article-title":"Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice","author":"De Hooge","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2020.115538_bb0415","doi-asserted-by":"crossref","DOI":"10.1038\/ijos.2015.2","article-title":"Diabetes mellitus related bone metabolism and periodontal disease","author":"Wu","year":"2015","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.bone.2020.115538_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061414","article-title":"Periodontal disease: a risk factor for diabetes and cardiovascular disease","author":"Liccardo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bone.2020.115538_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2017.08.001","article-title":"Periodontal disease and periodontal bacteria as triggers for rheumatoid arthritis","author":"Cheng","year":"2017","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.bone.2020.115538_bb0430","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0765.2006.00908.x","article-title":"Expression of suppressors of cytokine signaling in diseased periodontal tissues: a stop signal for disease progression?","author":"Garlet","year":"2006","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.bone.2020.115538_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2011.03.022","article-title":"Expression of suppressor of cytokine signaling 1 and 3 in ligature-induced periodontitis in rats","author":"De Souza","year":"2011","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.bone.2020.115538_bb0440","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/650812","article-title":"SOCS3 expression correlates with severity of inflammation, expression of proinflammatory cytokines, and activation of STAT3 and p38 MAPK in LPS-induced inflammation in vivo","author":"Chaves De Souza","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bone.2020.115538_bb0445","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.01070-08","article-title":"Involvement of SOCS3 in regulation of CD11c+ dendritic cell-derived osteoclastogenesis and severe alveolar bone loss","author":"Zhang","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bone.2020.115538_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.joen.2010.02.027","article-title":"Pro-inflammatory cytokines induce suppressor of cytokine signaling-3 in human periodontal ligament cells","author":"Fukushima","year":"2010","journal-title":"J. Endod."},{"key":"10.1016\/j.bone.2020.115538_bb0455","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.immunol.22.091003.090312","article-title":"The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response","author":"Alexander","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bone.2020.115538_bb0460","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.69.2.744-750.2001","article-title":"Interleukin-6 deficiency increases inflammatory bone destruction","author":"Balto","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bone.2020.115538_bb0465","doi-asserted-by":"crossref","DOI":"10.1210\/endo.138.11.5534","article-title":"Osteoclasts are present in gp130-deficient mice","author":"Kawasaki","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2020.115538_bb0470","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00623-07","article-title":"Periodontal bacterial DNA suppresses the immune response to mutans streptococcal glucosyltransferase","author":"Taubman","year":"2007","journal-title":"Infect. Immun."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220303185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220303185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:50:25Z","timestamp":1757613025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220303185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":94,"alternative-id":["S8756328220303185"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115538","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppressors of cytokine signaling (SOCS) proteins in inflammatory bone disorders","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115538"}}